GlassScriptPhysician profile
Elena Kaznatcheeva
NPI 1366482101
$1,456.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $370 · 2021: $123.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $338.52 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $179.23 | 2019-2020 | |
| Amgen INC. | $157.53 | 2019-2020 | |
| Genentech USA, INC. | $147.92 | 2019 | |
| Biogen, INC. | $134.06 | 2019 | |
| Abbott Laboratories | $123.33 | 2021 | |
| Avanir Pharmaceuticals, INC. | $100.00 | 2019 | |
| Allergan, INC. | $91.09 | 2019-2020 | |
| Emd Serono, INC. | $62.29 | 2019-2020 | |
| Opko Pharmaceuticals, LLC | $31.27 | 2019 | |
| Amneal Pharmaceuticals LLC | $24.61 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $23.11 | 2019 | |
| Eisai INC. | $16.56 | 2019 | |
| Assertio Therapeutics, INC. | $14.01 | 2019 | |
| Acorda Therapeutics, INC | $12.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Kaznatcheeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.